Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
Launched by NATIONAL CANCER INSTITUTE, NAPLES · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Recruiting
Keywords
ClinConnect Summary
The COESIT clinical trial is focused on improving cancer treatment by studying how tumors can be better understood through their genetic and molecular characteristics. The goal is to create a network of specialized laboratories in central and southern Italy that will help doctors provide more personalized care for cancer patients. This means that treatments can be tailored to match each patient's unique tumor profile, potentially leading to more effective therapies.
To participate in this trial, you need to be a cancer patient living in the central-southern regions of Italy. There are no restrictions on age or gender, so anyone who meets these criteria can join. If you choose to participate, you can expect to have your tumor analyzed in detail, which may help guide your treatment options. This trial is currently recruiting participants, and it represents an important step toward making cancer care more precise and individualized.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer patients
- • Patients from the central-southern regions
- Exclusion Criteria:
- • -
About National Cancer Institute, Naples
The National Cancer Institute (NCI) in Naples is a leading research institution dedicated to advancing the understanding and treatment of cancer through innovative clinical trials. As a prominent sponsor of cancer research, the NCI focuses on developing novel therapies, improving patient outcomes, and exploring cutting-edge methodologies in oncology. With a commitment to scientific rigor and collaboration, the NCI in Naples engages in partnerships with academic institutions and healthcare providers to facilitate groundbreaking studies that address critical challenges in cancer care. Their mission is to translate research findings into effective treatments, ultimately enhancing the lives of patients affected by cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Napoli, , Italy
Patients applied
Trial Officials
Antonella De Luca
Principal Investigator
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported